US to Resume J&J COVID Vaccinations Despite Rare Clot Risk

U.S. health officials have lifted an 11-day pause on Johnson & Johnson vaccinations following a recommendation by an expert panel.

Get our free mobile app

Advisers to the Centers for Disease Control and Prevention said Friday the benefits of the single-dose COVID-19 shot outweigh a rare risk of blood clots.

The CDC and Food and Drug Administration decided that J&J’s vaccine is critical to fight the pandemic — and that the small clot risk could be handled with warnings to help younger women decide if they should use that shot or an alternative.

European regulators earlier this week made a similar decision, deciding the clot risk was small enough to allow rollout.

LOOK: Answers to 30 common COVID-19 vaccine questions

While much is still unknown about the coronavirus and the future, what is known is that the currently available vaccines have gone through all three trial phases and are safe and effective. It will be necessary for as many Americans as possible to be vaccinated in order to finally return to some level of pre-pandemic normalcy, and hopefully these 30 answers provided here will help readers get vaccinated as soon they are able.

Filed Under: ap news, Associated Press, CDC, centers for disease, Coronavirus, COVID-19, covid-19 vaccine